Registration

Posters may be put up from 12:00

WELCOME LUNCH & TRADE EXHIBITION

Conference welcome

Scientific Programme Committee

Session 1

Chair: Joan Seoane

Pablo Umaña Roche Innovation Center Zurich, Switzerland

"Redirecting T-cells for Cancer Immunotherapy using Next Generation Bispecific Antibodies and Fusion Proteins"

Karin de Visser NKI, Netherlands

"Dissecting cancer cell-intrinsic mechanisms dictating the immune landscape of breast cancer"

Yotam Bar-Ephraim Hubrecht Institute, Netherlands

Proffered Paper 1: "Raising T cells against tumour-derived neo-antigens using epithelial organoid cultures"

Elena Garralda VHIO, Spain

"Challenges in early drug development of IO agents"

EXHIBITOR INTRODUCTIONS

Hear about the equipment and services offered by the companies in the trade exhibition.

COFFEE BREAK

Session 2

Chair: Johanna Joyce

POSTER SPOTLIGHTS

3 top-scoring abstracts will be presented in short 'flash talks' of 3 minutes each.

Neta Erez Tel Aviv University, Israel

Proffered Paper 2: "Shaping the immune landscape: Cancer-Associated Fibroblasts drive Th2 immunity in breast cancer progression and metastasis"

Luca Gattinoni National Cancer Institute, USA

"Harnessing T memory stem cells for adoptive cell transfer therapy of cancer"

Andrea Schietinger MSKCC, USA

"Molecular mechanisms defining tumor-specific T cell dysfunction and therapeutic reprogrammability"

EMBO Keynote Lecture

Richard Flavell Yale University School of Medicine, USA

"Study of the interface between human cancers and the human immune system in novel humanized mice"

NETWORKING RECEPTION

with drinks and a hot buffet dinner

POSTER DISCUSSION SESSION 1

Odd numbered posters will be presented

POSTER VIEWING

tea/coffee available

Industry SPOTLIGHT 1 - Nexcelom Bioscience

Sun Yung

“Novel plate-based detection method for T cell activation/proliferation, migration and cytotoxicity assay using image cytometry.”

Session 3

Chair: Andrea Schietinger

Alena Gros VHIO, Spain

"Harnessing the personalized antitumor T-cell response to treat cancer"

Johanna Joyce University of Lausanne, Switzerland

"Exploring and Therapeutically Exploiting the Tumour Microenvironment"

Keynote Lecture

George Coukos University of Lausanne, Switzerland

"Orchestration of antitumor immune response. Lesson for immunotherapy from the tumor microenvironment"

COFFEE BREAK

Session 4

Chair: Karin de Visser

POSTER SPOTLIGHTS

3 top-scoring abstracts will be presented in short 'flash talks' of 3 minutes each.

Joan Seoane VHIO, Spain

"Embryology meets Oncology. The role of LIF in cancer"

Marit Melssen University of Virginia, USA

Proffered Paper 3: "Formation and function of CD49a+ and CD49b+ CD8 T cells in a murine breast cancer model"

Sergio Quezada UCL Cancer Institute, UK

“T cell evolution in non-small cell lung cancer”

Industry SYMPOSIUM - Thermo Fisher Scientific

Tim Looney

"Predicting immunotherapy response and adverse events through next generation sequencing of peripheral blood T cell repertoires"

LUNCH

POSTER DISCUSSION SESSION 2

Even numbered posters will be presented. Tea & coffee will be available.

Session 5

Chair: Sergio Quezada

Graham Pawelec University of Tübingen, Germany

"Immunotherapy of Cancer: Triumphs and Challenges and the Impact of Immunosenescence"

Danique Duits NKI, Netherlands

Proffered Paper 4: "Systemic expansion of pro-metastatic neutrophils is enhanced by MET amplification in breast cancer"

Kris Thielemans VUB, Belgium

"mRNA therapeutics: ex-vivo and in-vivo modification of antigen presenting cells"

DISCUSSION FORUM

until 18:45

The discussion will be led by Joan Seoane, Zlatko Trajanosky and George Coukos, and participants are invited to contribute to the conversation.

"How to introduce precision medicine principles to immuno-oncology"

Conference Dinner

El Principal del Eixample

Ticketed optional extra

POSTER VIEWING

tea/coffee available

Industry SPOTLIGHT 2 - 10x Genomics

Hannes Arnold

"Single Cell and Spatial Gene Expression Analysis of the Tumor Microenvironment"

Session 6

Chair: Alena Gros

Núria Lopez-Bigas ICREA & IRB Barcelona, Spain

"Biological and clinical relevance of tumor mutations"

Zlatko Trajanosky Innsbruck Medical University, Austria

"Computing and probing immunity in colorectal cancer"

Jitske van den Bulk LUMC, Netherlands

Proffered Paper 5: "Detection of neo-antigen-specific T cell responses in low mutation burden colorectal cancers for personalized therapies"

COFFEE BREAK

Miguel Sanmamed University of Navarra, Spain

"Novel patient-derived tumor models for immunotherapy development”

Closing Keynote

Laurence Zitvogel Gustave Roussy, France

"The unsuspected role of gut microbiota in cancer therapies"

Summary & Awards

Scientific Programme Committee

LUNCH & DEPART